In this case, the Cl signal increased significantly above the baseline indicating an increased pigment concentration (detection) at the surface of the paint film.
This second view would be consistent with data from a prospective study, in which increased baseline MN or chromosome aberration frequencies indicated an increased cancer risk (Rossner et al, 2005; Bonassi et al, 2007).
Multivariable-adjusted HRs indicated an increased risk of incident diabetes with elevated baseline depressive symptoms (HR 1.13 [95% CI 1.07 1.20]) and antidepressant use (1.18 [1.18–1.18]).
For VC and IC, an increase ≥ 12% and 200 ml compared with baseline indicated a positive bronchodilator test.
The higher rates of background retinopathy and above at baseline in the Royal Devon and Exeter data may indicate an increased risk of retinopathy in this population.
On the other hand, in terms of immunological response, higher viral loads at baseline indicated greater increase in CD4 cell count.
Note that negative values indicate a relative decrease in the alpha-band (event-related desynchronization) during the experimental condition compared to the baseline condition, while positive values indicate an increase of alpha-band power during the experimental condition (event-related synchronization).
Exposure to intermittent hypoxia did not alter daily baseline spectral features that would indicate an increase of sympathetic cardiac activity: low frequency (0.05 – 0.15 Hz) activity was unaffected and the ratio of low- to -high frequency activity remained less than unity indicating a predominance of high frequency activity.
This prospective study of 2406 men and 2569 women aged 18 74 years at baseline indicated that a 2.25 kg increase in weight over 16 years was associated with a 20% rise in the summed severity of six CVD risk factors (high-density lipoprotein cholesterol [HDL-C], total cholesterol, BMI, systolic blood pressure, triglycerides, and plasma glucose) in men and a 37% increase in women.
Compared to baseline, a positive or negative value indicates an increase or decrease in dose at follow-up, respectively.
